
A mitochondrial-derived peptide with powerful cytoprotective effects that protects against age-related diseases and cellular stress.
Subcutaneous injection
1-5 mg weekly (research dosing)
Humanin binds to IGFBP-3 and BAX, inhibiting apoptosis and protecting cells from oxidative stress. It activates STAT3 signaling and reduces amyloid-beta toxicity, providing broad cytoprotective effects.
Discovered in 2001 from Alzheimer's patient brain tissue. Extensive preclinical evidence for neuroprotection, cardioprotection, and metabolic improvement. Circulating levels correlate with longevity in centenarian studies.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Peptide therapy should only be administered under the supervision of a qualified healthcare provider. Always consult your physician before starting any new treatment protocol.